Fig. 3From: A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients111In-OTSA-101 whole body planar scintigraphy repeated over time for patient 8 showing increasing lesions uptake compare to mediastinal blood poolBack to article page